Sawai Group Holdings Co., Ltd. (4887)
JPX JPX Primary 
OTC PINK Summary
Sawai Group Holdings Co., Ltd. (4887) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Sawai Group Holdings Co., Ltd. ever had a stock split?
Sawai Group Holdings Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Mitsuo Sawai CEO | JPX Exchange | JP3323040000 ISIN |
| Japan Country | 3,310 Employees | 29 Sep 2026 Last Dividend | 27 Sep 2024 Last Split | - IPO Date |
Overview
Sawai Group Holdings Co., Ltd. is a prominent entity in the pharmaceutical industry, focusing on the research, development, manufacturing, and marketing of generic pharmaceuticals. Founded in 1929 and based in Osaka, Japan, the company has expanded its reach to include operations in both Japan and the United States. By offering an extensive range of generic drugs, Sawai Group Holdings stands as a key player in the global effort to make essential medications more accessible and affordable. Through its subsidiaries, the company efficiently caters to diverse medical needs, ensuring a broad spectrum of high-quality drugs are available to healthcare providers and patients alike.
Products and Services
Sawai Group Holdings Co., Ltd. offers a comprehensive portfolio of generic drugs, encompassing various dosage forms and therapeutic areas. Each product is designed to meet the rigorous standards of quality, safety, and efficacy, thus supporting the company's mission to contribute to healthcare systems worldwide. The range of their products and services includes:
- Tablets, Oral Dispersing Tablets, Capsules, and Granules: Solid dosage forms designed for ease of use and effective delivery of medication for multiple health conditions.
- Injectables: Sterile preparations used for administration via injection, catering to both acute and chronic medical needs.
- Tapes, Ophthalmic or Nasal Solutions, and Syrups: Specialized formulations for targeted delivery methods, including topical, ocular, nasal, and oral administration, to ensure optimum effectiveness and patient compliance.
- Therapeutic Areas: The company's products cover a wide range of therapeutic areas, ensuring comprehensive healthcare solutions. These include:
- Cardiovascular
- Gastro-intestinal
- Blood/Body Fluid
- Metabolic Disorders
- Antibiotics
- Central Nervous System
- Antiallergics
- Anti-cancer
- Urogenital Organs and Anus
- Chemotherapeutic and Antineoplastic Agents
- Respiratory System
- Vitamin Preparations: Nutritional supplements to support overall health and well-being, addressing deficiencies and complementing treatment regimens.
- Distribution: Sawai Group Holdings utilizes a wide network of distributors, wholesalers, and retailers to ensure their products are readily available in Japan and the United States, thereby facilitating access to essential medications for a wide population.
